Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
Researchers compared RO4917838 and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little Rock
A Randomized, Double-blind Study of Repetitive Transcranial Magnetic Stimulation for Cognitive Deficits in Chronic Patients With Schizophrenia in a Chinese Han Population
This study has finished and is no longer accepting participants.
Location not clearly listedA Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis
This study has finished and is no longer accepting participants.
Multiple locations, including La HabraResearchers compared LY2140023 and Aripiprazole, tracking side effects to assess safety and tolerability in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Garden Grove
Coping@School: A Study of School Absenteeism and Student Well-being in Elementary Schools
This study is by invitation only.
In OsloThis study evaluates the safety of Seltorexant for people with depression.
This study ended early.
Multiple locations, including PhoenixA Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of Seltorexant 20 mg as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy and an Open-labeled Long-term Safety Extension Treatment With Seltorexant
This study has finished and is no longer accepting participants.
Multiple locations, including AnaheimA Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of Seltorexant 20 mg as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy
This study ended early.
Multiple locations, including PhoenixDouble-Blind, Randomized, Parallel-Group Study With Quetiapine Extended Release as Comparator to Evaluate the Efficacy and Safety of Seltorexant 20 mg as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamA Phase 1b, Randomized, Double-blind, Placebo-controlled Trial to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Oral Doses of SEP-380135 in Adults With Schizophrenia or With a Major Depressive Episode Associated With Bipolar I or II Disorder or Major Depressive Disorder
This study has finished and is no longer accepting participants.
In Los AlamitosA Study of Sertraline to Prevent PTSD
Read the official source — NCT00182078A Study of Sertraline to Prevent PTSD
This study has finished and is no longer accepting participants.
In BostonThis study evaluated the safety and effectiveness of SLS-002 for people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including OrangeWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.